Quinn Opportunity Partners LLC RA PHARMACEUTICALS ownership

RA PHARMACEUTICALS's ticker is RARX and the CUSIP is 74933V108. A total of 154 filers reported holding RA PHARMACEUTICALS in Q4 2019. The put-call ratio across all filers is 7.38 and the average weighting 0.4%.

Quinn Opportunity Partners LLC ownership history of RA PHARMACEUTICALS
ValueSharesWeighting
Q4 2019$70415,0000.05%